Caribou Biosciences (CRBU) Other Non Operating Income (2020 - 2026)

Caribou Biosciences (CRBU) has reported Other Non Operating Income for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income fell 59.1% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $7.4 million (down 53.42% YoY), while the FY2025 annual figure was $8.8 million, down 49.57% from the prior year.
• Other Non Operating Income retreated to $1.2 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $5.3 million in Q4 2024 and bottomed at $257000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $2.8 million across 5 years, with a median of $2.8 million in 2023.
• Annual changes were most pronounced in 2022 — Other Non Operating Income soared 1506.25% — and 2026, when it slumped 59.1%.
• Caribou Biosciences' Other Non Operating Income stood at $2.3 million in 2022, then surged by 106.61% to $4.8 million in 2023, then gained by 10.26% to $5.3 million in 2024, then tumbled by 58.57% to $2.2 million in 2025, then sank by 45.68% to $1.2 million in 2026.
• Business Quant data shows CRBU's Other Non Operating Income at $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $1.9 million in Q3 2025.